Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Pharmacol Res. 2022 Nov 20;187:106560. doi: 10.1016/j.phrs.2022.106560

Figure 9. CB2 and GFP mRNA expression patterns in various tissues derived from advillinCre/+;CB2f/f mice and CB2f/f mice.

Figure 9.

Comparisons of (A, B, C, D) CB2 mRNA and (E, F, G,H) GFP mRNA in (A, B) DRG, (C, D) paw skin, (E, F) lumbar spinal cord and (G,H) spleen between advillinCre/+;CB2f/f mice and CB2f/f mice (n=6-10/group). AdvillinCre/+;CB2f/f mice display lower levels of CB2 and GFP mRNA in lumbar DRG relative to CB2f/f mice, but no difference in expression levels between genotypes for either mRNA species in paw skin, spinal cord and spleen. Values were calculated using the 2(−ΔΔCt) method. GAPDH was used as reference gene. Data are expressed as mean ± S.E.M. **p < 0.01, unpaired sample two tailed t-test.